Greenland Mines Ltd. (NASDAQ: GRML) has released a shareholder letter from President Dr. Bo Møller Stensgaard, detailing recent progress following the company's rebranding in March. Key developments include the closing of the Sarfartoq Neodymium-Praseodymium Rare Earths Project acquisition on Sept. 1 and ongoing work at the Skaergaard palladium-gold-platinum project. The letter emphasizes the company's strategic positioning in the critical minerals market, with significant resource estimates and development milestones ahead.
At the Sarfartoq project, Greenland Mines cited an independent Initial Assessment that outlines a high-case pre-tax net present value (NPV) of approximately $2.05 billion and an internal rate of return (IRR) of 118.6%, including Indicated and Inferred Mineral Resources. The project also boasts an updated resource estimate of 6.9 million tonnes of Indicated resources at 1.60% total rare earth oxides (TREO) and 5.3 million tonnes of Inferred resources at 0.96% TREO. Notably, Neo Performance Materials holds a strategic stake in the company and has offtake rights for up to 60% of future Sarfartoq production, underlining the project's commercial viability.
At Skaergaard, Greenland Mines reported that its July 2026 S-K 1300 Technical Report Summary increased Indicated palladium equivalent (PdEq) grade by 36% and contained Indicated PdEq ounces by 31% compared with the 2022 estimate. The company is currently conducting a 2026 field program encompassing drilling, bulk sampling, geotechnical work, environmental baseline studies, and surveys. Bulk material from the project is slated for metallurgical and processing flowsheet testing at GTK Mintec in Finland, a critical step toward advancing the project's development.
Looking ahead, Greenland Mines outlined its remaining 2026 milestones: advancing Sarfartoq toward targeted infill drilling and a pre-feasibility study, moving Skaergaard toward an initial assessment evaluating a mining scenario, and developing its broader North Atlantic Critical Metals Corridor strategy. This corridor aims to link Greenland's mineral resources with allied downstream jurisdictions and industrial infrastructure, positioning the company to capitalize on growing demand for critical minerals.
The updates underscore Greenland Mines' dual focus on rare earth elements and precious metals, with a portfolio that includes two operating divisions: Mining and Biotech. The biotech division includes Klotho's KLTO-202 primary indication for ALS, but the company's core strategy remains centered on building a multi-asset platform with exposure to rare earth magnet materials and precious metals. As the company advances its projects, it is poised to play a significant role in the critical minerals supply chain, particularly for Western markets seeking alternatives to dominant Chinese sources.
Investors can access the full press release for more details. The company continues to progress its projects, with the Sarfartoq acquisition and Skaergaard development expected to be pivotal in achieving its strategic goals. Greenland Mines' focus on the North Atlantic Critical Metals Corridor highlights its commitment to integrating Greenland's resources with allied processing capabilities, potentially enhancing supply chain security for critical minerals.
